Metastatic Prostate Cancer: ASCO Tumor Boards

This is a case-based activity that includes discussion of a 65 year old healthy man dx SP RRP revealing pT3a, Gleason 4+3= 7 and tertiary of 5, pre-op PSA 2.26 ng/ml. Pre treatment bone scan and CT negative for metastatic disease. Post-OP, PSA became undetectable until ~3.3 yrs later when it measured 0.08 ng/ml.  Along with the patient case, there is a discussion board on ASCO Connection, where users can post comments/questions to each other and to the faculty.   At the end of this course you should be able to:

  1. Review and evaluate recent data that should be considered in the management of men with metastatic prostate cancer.
  2. Summarize contemporary treatment paradigms of men with metastatic prostate cancer
  3. Analyze the mechanisms of action and clinical application of the current armamentarium for men with metastatic prostate cancer
  4. Explain the current clinical states model of prostate cancer
This activity was made available on 1/21/2015 and will be reviewed on an annual basis to determine continued availability. A maximum of 1 AMA PRA Category 1 Credit(s) ™ credit is available.

Competencies Addressed

Medical Knowledge (ACGME, AAPA)

Health Promotion, Health Protection, Disease Prevention, and Treatment (ONS)

Note: This course is now accessible through mobile devices as well as personal computers